National Institutes of Health (NIH)

NIH is playing a pivotal role in supporting the innovative science underpinning the effort to reduce the incidence of HIV domestically by 75% in 5 years, and by 90% by 2030.

Scientists have determined that La Crosse virus, which can cause inflammation of the brain in children, affects brain cells differently depending on their developmental stage.

NIH-funded research shows no difference in efficacy or adverse effects of commonly used treatments.

Study Leaders Publish Results from NIH-DRC-WHO Clinical Trial of Four Experimental Therapies.

Researchers used data from 46,709 women in the Sister Study.

Yet transmission-risk misunderstandings persist, finds large NIH-supported study.

Blinatumomab is superior to standard chemotherapy for children and young adults with high- or intermediate-risk B-cell acute lymphoblastic leukemia that has relapsed.

NIH-funded finding may alter policies at hospitals where fresh red cells are preferentially used.

Plan outlines efforts to intensify ongoing HBV research.

NIH study may inform ways to reduce male-to-female HIV transmission.